Application

18529915 · BISPECIFIC CHIMERIC ANTIGEN RECEPTOR THAT BINDS CD19 AND CD20, ENCODING NUCLEIC ACID MOLECULES THEREOF AND METHODS OF USE THEREOF TO TREAT CANCER

Filed 2023-12-05 · Granted · Patent 12594321 (2026-04-07) The official file ↗The patent and its PDF ↗ · Art unit 1647 · Examiner Robert S Landsman Easy · CPC A61K 38/1774 · The Trustees of the University of Pennsylvania · K&L Gates - Novartis

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

11.2 mo

to disposition 28.1 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.